206 related articles for article (PubMed ID: 32739872)
1. Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.
Wang S; Tian S; Li Y; Zhan N; Guo Y; Liu Y; Xu J; Ma Y; Zhang S; Song S; Geng W; Xia H; Ma P; Wang X; Liao T; Duan Y; Jin Y; Dong W
EBioMedicine; 2020 Aug; 58():102924. PubMed ID: 32739872
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.
Wu A; Liang Z; Yuan S; Wang S; Peng W; Mo Y; Yang J; Liu Y
Front Oncol; 2021; 11():775079. PubMed ID: 34950585
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prediction model for tuberculous pleural effusion: a large cohort study and external validation.
Liu Y; Liang Z; Yuan S; Wang S; Guo F; Peng W; Yang J; Wu A
Respir Res; 2022 May; 23(1):134. PubMed ID: 35624515
[TBL] [Abstract][Full Text] [Related]
4. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
Lin L; Li S; Xiong Q; Wang H
BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
[TBL] [Abstract][Full Text] [Related]
6. Development and validation a simple scoring system to identify malignant pericardial effusion.
Jin X; Hu L; Fang M; Zheng Q; Yuan Y; Lu G; Li T
Front Oncol; 2022; 12():1012664. PubMed ID: 36531065
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
9. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
10. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
12. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
13. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
[TBL] [Abstract][Full Text] [Related]
14. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
15. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.
Zhang Y; Li X; Liu J; Hu X; Wan C; Zhang R; Shen Y
Ann Med; 2021 Dec; 53(1):558-566. PubMed ID: 33818231
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
Zhang F; Hu L; Wang J; Chen J; Chen J; Wang Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27976800
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of pleural effusion--carcinoembryonic antigen (CEA) and adenosine deaminase (ADA) activities in pleural fluids].
Yagi S
Kekkaku; 1990 Dec; 65(12):775-83. PubMed ID: 2077254
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]